We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.3B
AUM Growth
+$3.91B
Cap. Flow
+$3.81B
Cap. Flow %
23.39%
Top 10 Hldgs %
11.9%
Holding
1,520
New
601
Increased
279
Reduced
223
Closed
402

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$113M
2
AMZN icon
Amazon
AMZN
+$91.8M
3
EXPE icon
Expedia Group
EXPE
+$83.2M
4
POT
Potash Corp Of Saskatchewan
POT
+$81.4M
5
C icon
Citigroup
C
+$80.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.69%
2 Technology 10.21%
3 Healthcare 8.86%
4 Energy 7.96%
5 Financials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSN
1101
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$49K ﹤0.01%
+14,700
New +$54.1K
ALIM
1102
DELISTED
Alimera Sciences
ALIM
$48K ﹤0.01%
+692
New +$47.7K
CBB
1103
DELISTED
Cincinnati Bell Inc.
CBB
$48K ﹤0.01%
+2,530
New +$46.2K
ENZ
1104
DELISTED
Enzo Biochem, Inc.
ENZ
$45K ﹤0.01%
+14,820
New +$41.7K
STCN
1105
DELISTED
Steel Connect, Inc. Common Stock
STCN
$44K ﹤0.01%
1,393
-593
-30% -$19.8K
CBAY
1106
DELISTED
Cymabay Therapeutics
CBAY
$39K ﹤0.01%
+14,315
New +$58.8K
GSAT icon
1107
Globalstar
GSAT
$10.8B
$38K ﹤0.01%
1,215
-941
-44% -$36.6K
TSYS
1108
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$38K ﹤0.01%
11,450
-6,340
-36% -$21.3K
LCTX icon
1109
Lineage Cell Therapeutics
LCTX
$278M
$37K ﹤0.01%
+12,700
New +$49.2K
RSYS
1110
DELISTED
Radisys Corp
RSYS
$30K ﹤0.01%
+11,805
New +$29K
EIGR
1111
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$29K ﹤0.01%
+51
New +$141K
BEBE
1112
DELISTED
Bebe Stores Inc
BEBE
$28K ﹤0.01%
1,415
-940
-40% -$26.5K
VERU icon
1113
Veru
VERU
$37.4M
$23K ﹤0.01%
+1,255
New +$33.6K
HTCH
1114
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$20K ﹤0.01%
11,450
-17,020
-60% -$38K
FLNA
1115
Filana Therapeutics
FLNA
$48.1M
$19K ﹤0.01%
+1,536
New +$21K
AAOI icon
1116
Applied Optoelectronics
AAOI
$11.5B
-22,110
Closed -$307K
AAP icon
1117
Advance Auto Parts
AAP
$3.49B
-235,033
Closed -$35.2M
ABT icon
1118
CALL
Abbott
ABT
$187B
-100,000
Closed -$4.63M
ABT icon
1119
Abbott
ABT
$187B
-256,540
Closed -$11.9M
ACGL icon
1120
Arch Capital
ACGL
$33.6B
-1,049,067
Closed -$21.5M
AIG icon
1121
American International
AIG
$41.3B
-289,716
Closed -$15.9M
ALTO icon
1122
Alto Ingredients
ALTO
$340M
-26,000
Closed -$281K
AMAT icon
1123
PUT
Applied Materials
AMAT
$428B
-100,000
Closed -$2.26M
AMCX icon
1124
AMC Global Media
AMCX
$489M
-373,271
Closed -$28.6M
AMH icon
1125
American Homes 4 Rent
AMH
$12.5B
-200,000
Closed -$3.31M

Similar funds

Balyasny Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Balyasny Asset Management held 1,520 positions worth $16.3B, up 32% from $12.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Balyasny Asset Management deployed $3.81B of net new capital in Q2 2015, opening 601 new positions and adding to 279 existing holdings. Its largest new stake was eBay: 6,249,614 shares worth $158M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $91.8M trimmed.

  • Balyasny Asset Management's largest Q2 2015 buy was eBay: 6,249,614 shares worth $158M.
  • Balyasny Asset Management added most to Time Warner Inc in Q2 2015, an estimated $160M increase.
  • Balyasny Asset Management's biggest Q2 2015 reduction was Amazon, cutting an estimated $91.8M.
  • Balyasny Asset Management fully exited Gilead Sciences in Q2 2015, selling an estimated $113M.
  • Balyasny Asset Management's ten largest holdings make up 12% of its $16.3B portfolio in Q2 2015.
  • Balyasny Asset Management opened 601 new positions and closed 402 in Q2 2015.
  • Balyasny Asset Management's portfolio value rose 32% quarter-over-quarter to $16.3B.

Based on Balyasny Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.